Satler LF - Search Results

1

Satler LF. Satler LF. Catheter Cardiovasc Interv. 2012 Feb 1;79(2):253-4. doi: 10.1002/ccd.24298. Catheter Cardiovasc Interv. 2012. PMID: 22271554 No abstract available.

2

Safety and efficacy of everolimus-eluting stents versus paclitaxel-eluting stents in a diabetic population.

Laynez A, Sardi G, Hauville C, Barbash IM, Pakala R, Torguson R, Xue Z, Satler LF, Pichard AD, Waksman R. Laynez A, et al. Among authors: satler lf. Catheter Cardiovasc Interv. 2013 Apr;81(5):759-65. doi: 10.1002/ccd.24438. Epub 2012 Apr 23. Catheter Cardiovasc Interv. 2013. PMID: 22488756

3

The influence of advancing age on implantation of drug-eluting stents.

Tian W, Mahmoudi M, Lhermusier T, Kiramijyan S, Chen F, Torguson R, Suddath WO, Satler LF, Pichard AD, Waksman R. Tian W, et al. Among authors: satler lf. Catheter Cardiovasc Interv. 2016 Oct;88(4):516-521. doi: 10.1002/ccd.26333. Epub 2015 Nov 25. Catheter Cardiovasc Interv. 2016. PMID: 26603135

4

Does direct stenting with drug-eluting stents improve outcome? A meta-analysis of 10,900 patients.

Magalhaes MA, Minha S, Lhermusier T, Pendyala L, Escarcega RO, Baker NC, Torguson R, Satler LF, Pichard A, Waksman R. Magalhaes MA, et al. Among authors: satler lf. Catheter Cardiovasc Interv. 2017 Aug 1;90(2):213-222. doi: 10.1002/ccd.26861. Epub 2016 Nov 10. Catheter Cardiovasc Interv. 2017. PMID: 27862877 Review.

5

The tricks of re-crossing a deployed stent.

Satler LF. Satler LF. Catheter Cardiovasc Interv. 2000 Nov;51(3):314-5. doi: 10.1002/1522-726x(200011)51:3<314::aid-ccd16>3.0.co;2-z. Catheter Cardiovasc Interv. 2000. PMID: 11066115 No abstract available.

6

Use of restenting should be minimized with intracoronary radiation therapy for in-stent restenosis.

Cha DH, Malik IA, Cheneau E, Ajani AE, Leborgne L, Wolfram R, Porrazzo M, Satler LF, Kent KM, Pichard AD, Pinnow E, Lindsay J, Waksman R. Cha DH, et al. Among authors: satler lf. Catheter Cardiovasc Interv. 2003 May;59(1):1-5. doi: 10.1002/ccd.10490. Catheter Cardiovasc Interv. 2003. PMID: 12720231

7

Use of IIb/IIIa inhibitors in patients with in-stent restenosis treated with intracoronary gamma-radiation. Integrilin WRIST.

Waksman R, Ajani AE, Gruberg L, Pinnow E, GebreEyesus A, Deible R, Satler LF, Pichard AD, Torguson R, Kent KM, Suddath W, Lindsay J. Waksman R, et al. Among authors: satler lf. Catheter Cardiovasc Interv. 2004 Jun;62(2):162-6. doi: 10.1002/ccd.20054. Catheter Cardiovasc Interv. 2004. PMID: 15170704 Clinical Trial.

8

Underexpansion of sirolimus-eluting stents: incidence and relationship to delivery pressure.

Cheneau E, Satler LF, Escolar E, Suddath WO, Kent KM, Weissman NJ, Waksman R, Pichard AD. Cheneau E, et al. Among authors: satler lf. Catheter Cardiovasc Interv. 2005 Jun;65(2):222-6. doi: 10.1002/ccd.20350. Catheter Cardiovasc Interv. 2005. PMID: 15900554

9

Impact of sirolimus-eluting stents on outcomes of patients treated for acute myocardial infarction by primary angioplasty.

Cheneau E, Rha SW, Kuchulakanti PK, Stabile E, Kinnaird T, Torguson R, Pichard AD, Satler LF, Kent KM, Waksman R. Cheneau E, et al. Among authors: satler lf. Catheter Cardiovasc Interv. 2005 Aug;65(4):469-72. doi: 10.1002/ccd.20395. Catheter Cardiovasc Interv. 2005. PMID: 15988741

10

Impact of overlapping drug-eluting stents in patients undergoing percutaneous coronary intervention.

Chu WW, Kuchulakanti PK, Torguson R, Wang B, Clavijo LC, Suddath WO, Pichard AD, Satler LF, Kent KM, Waksman R. Chu WW, et al. Among authors: satler lf. Catheter Cardiovasc Interv. 2006 Apr;67(4):595-9. doi: 10.1002/ccd.20665. Catheter Cardiovasc Interv. 2006. PMID: 16532495

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

775 results

Search Page